Multivalent display of engineered HIV-1 envelope trimers on silica nanoparticles for targeting and in vitro activation of germline VRC01 B cells.

MLA

Peterhoff, David, et al. “Multivalent Display of Engineered HIV-1 Envelope Trimers on Silica Nanoparticles for Targeting and in Vitro Activation of Germline VRC01 B Cells.” European Journal of Pharmaceutics & Biopharmaceutics, vol. 181, Dec. 2022, pp. 88–101. EBSCOhost, https://doi.org/10.1016/j.ejpb.2022.10.007.

APA

Peterhoff, D., Thalhauser, S., Neckermann, P., Barbey, C., Straub, K., Nazet, J., Merkl, R., Laengst, G., Breunig, M., & Wagner, R. (2022). Multivalent display of engineered HIV-1 envelope trimers on silica nanoparticles for targeting and in vitro activation of germline VRC01 B cells. European Journal of Pharmaceutics & Biopharmaceutics, 181, 88–101. https://doi.org/10.1016/j.ejpb.2022.10.007

Chicago

Peterhoff, David, Stefanie Thalhauser, Patrick Neckermann, Clara Barbey, Kristina Straub, Julian Nazet, Rainer Merkl, Gernot Laengst, Miriam Breunig, and Ralf Wagner. 2022. “Multivalent Display of Engineered HIV-1 Envelope Trimers on Silica Nanoparticles for Targeting and in Vitro Activation of Germline VRC01 B Cells.” European Journal of Pharmaceutics & Biopharmaceutics 181 (December): 88–101. doi:10.1016/j.ejpb.2022.10.007.